Samantha Bioseh
Family · Huntsville, TXNPI 1861962136
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,548 of the $3,832 with a category attached, or 66.5%. 25 manufacturers reported payments, led by Biohaven Pharmaceuticals, Inc. at 38.6% of the total. Reporting peaked in 2021 at $1,568 and has fallen 52.3% since, to $749 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 105 payments — averaging $36.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$1K
- AbbVie$608
- Novo Nordisk$277
- Johnson & Johnson$224
- AstraZeneca$201
- Exact Sciences$155
- plus $888 from 19 others
What the payments were for
- Consulting fees$1,20031%
- Food & beverage$2,54867%
- Education$832%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 17 | $1,479 |
| AbbVie | 40 | $608 |
| Novo Nordisk | 10 | $277 |
| Johnson & Johnson | 5 | $224 |
| AstraZeneca | 4 | $201 |
| Exact Sciences | 3 | $155 |
| Kowa Pharmaceuticals America, Inc. | 1 | $128 |
| Lilly USA, LLC | 1 | $125 |
| Bayer | 1 | $120 |
| Sanofi-aventis U.S. LLC | 4 | $80 |
| Astellas Pharma US Inc | 1 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Eisai Inc. | 1 | $34 |
| Optinose US, Inc. | 1 | $29 |
| Tris Pharma Inc | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $22 |
| Pfizer | 1 | $22 |
| GSK | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Tolmar, Inc. | 1 | $13 |
| Sumitomo Pharma America, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,200
- ZORYVE$128
- AIRSUPRA$125
- MOUNJARO$125
- Wegovy$122
- The Cologuard Plus Collection Kit$121
- QULIPTA$121
- XARELTO$120
- Kerendia$120
How this compares
$3,832 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Other family in Huntsville
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.